Pelthos Therapeutics, Inc. (PTHS)
22.35
+0.16
(+0.72%)
USD |
NYAM |
Sep 28, 16:00
22.35
0.00 (0.00%)
After-Hours: 17:27
Pelthos Therapeutics Cash from Operations (Annual) : -22.59M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -22.59M |
| December 31, 2024 | -5.792M |
| December 31, 2023 | -0.981M |
| Date | Value |
|---|---|
| December 31, 2022 | -1.567M |
| December 31, 2021 | -1.593M |
| December 31, 2020 | -3.626M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Travere Therapeutics, Inc. | 37.78M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |
| Savara, Inc. | -101.04M |